{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:59:15Z","timestamp":1785308355478,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Coccidioidal meningitis (CM) is a life-threatening infection with limited treatment options. Small series have reported success with isavuconazole; however, limited data exist on cerebrospinal fluid (CSF) penetration. Paired plasma and CSF isavuconazole concentrations were measured. Eleven CSF levels were tested, (7 ventricular, 4 lumbar) in three CM patients. Ventricular CSF levels were undetectable despite detectable plasma levels. All lumbar CSF levels were detectable (mean 1.00\u00a0\u00b5g\/ml). Three pairs of lumbar CSF\/plasma concentrations taken within 1 h of each other yielded a mean CSF\/plasma ratio of 0.31. Isavuconazole was detectable in lumbar but not ventricular CSF in three patients treated for refractory CM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Isavuconazole is a triazole antifungal that has been used as salvage therapy in the treatment of coccidioidal meningitis (CM). Few data exist characterizing its concentration in the cerebrospinal fluid (CSF). We report tandem plasma and CSF concentrations of isavuconazole in three patients with CM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myab035","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T23:11:30Z","timestamp":1623885090000},"page":"939-942","source":"Crossref","is-referenced-by-count":16,"title":["Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7998-2312","authenticated-orcid":false,"given":"Matthew R","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of California Los Angeles Ronald Reagan Medical Center, Los Angeles, CA, 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California Ronald Reagan Los Angeles Medical Center, Los Angeles, CA, 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pryce","family":"Gaynor","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California Ronald Reagan Los Angeles Medical Center, Los Angeles, CA, 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K","family":"McCreary","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, UPMC, Pittsburgh, PA, 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Allyn","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California Ronald Reagan Los Angeles Medical Center, Los Angeles, CA, 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"2021090223512461100_bib1","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021090223512461100_bib2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cid\/cir642","article-title":"Treatment of refractory coccidioidomycosis with voriconazole or posaconazole","volume":"53","author":"Kim","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021090223512461100_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.idc.2015.10.008","article-title":"Coccidioidomycosis","volume":"30","author":"Stockamp","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2021090223512461100_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090223512461100_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myz103","article-title":"Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system","volume":"58","author":"Schwartz","year":"2019","journal-title":"Med Mycol"},{"key":"2021090223512461100_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00524-19","article-title":"Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease","volume":"63","author":"Lee","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090223512461100_bib7","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkz050","article-title":"Isavuconazole brain penetration in cerebral aspergillosis","volume":"74","author":"Lamoth","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021090223512461100_bib8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/cid\/ciaa358","article-title":"Isavuconazole as primary anti-fungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase II study","volume":"72","author":"Bose","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021090223512461100_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkw433","article-title":"Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis","volume":"72","author":"Gebremariam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021090223512461100_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090223512461100_bib11","first-page":"e9315","article-title":"Comparison of ventricular and lumbar cerebrospinal fluid composition","volume":"12","author":"Podkovik","year":"2020","journal-title":"Cureus"},{"key":"2021090223512461100_bib12","first-page":"42","article-title":"A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases","volume":"3","author":"Chamberlain","year":"2001","journal-title":"Neuro Oncol"},{"key":"2021090223512461100_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofz324","article-title":"When ventricular cerebrospinal fluid assessment misleads: basal meningitis and the importance of lumbar puncture sampling","volume":"6","author":"Khan","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2021090223512461100_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7326\/0003-4819-77-2-243","article-title":"Ventricular fluid and the management of coccidioidal meningitis","volume":"77","author":"Goldstein","year":"1972","journal-title":"Ann Intern Med"},{"key":"2021090223512461100_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin Microbiol Rev"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myab035\/38875411\/myab035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/9\/939\/39740657\/myab035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/9\/939\/39740657\/myab035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T21:08:40Z","timestamp":1630616920000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/9\/939\/6304833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,6,18]]},"published-print":{"date-parts":[[2021,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myab035","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,6,18]]}}}